Vir Biotechnology, Inc. (VIR) Gross margin 2019–2025
Vir Biotechnology, Inc. (VIR) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2025 · since FY2019: 100.0% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 100.0% | +1.1 pp |
| FY2024 | 98.9% | +2.1 pp |
| FY2023 | 96.8% | +5.8 pp |
| FY2022 | 90.9% | -3.0 pp |
| FY2021 | 94.0% | -6.0 pp |
| FY2020 | 100.0% | +0.0 pp |
| FY2019 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice